Effects of PRJ-205 on Performance in Trained Young Subjects

Bioiberica

Status: Completed

Conditions: Healthy

Treatments: Other: Placebo; Dietary Supplement: PRJ-205

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT02726516

PRJ-205

Details and patient eligibility

About

Compare a dietary supplement (PRJ-205) and placebo during 1 or 4 days on aerobic exercise performance, oxidative stress and muscle damage.

The hypothesis is that supplementation with PRJ-205 improve aerobic performance

Full description

Twenty young active males will be recruited and randomized to either placebo or PRJ-205. Subjects will take the designated treatment in an acute dosage and chronically, 4 days of treatment.

They will undergo 3 exercise tasks (before the administration of the product, 1.5h after the acute administration of the product and after 4 days of treatment). VO2max and anaerobic threshold will be measured during the tests. Blood samples will be taken to measure muscle damage and oxidative stress.

Enrollment: 20 patients

Sex: Male

Ages: 18 to 30 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Male
• Healthy
• Physically active

Exclusion criteria

• known cardiovascular, pulmonary or metabolic disease
• any medical condition that could affect the development and safety of the exercise task

Trial design

20 participants in 2 patient groups, including a placebo group

Treated

Experimental group

Description:

Treated volunteers will be administered one dose of PRJ-205 1,5 hours before the exercise task for the acute testing and will be taking one dose per day of PRJ-205 for 4 days for the chronic testing.

Treatment:

Dietary Supplement: PRJ-205

Placebo

Placebo Comparator group

Description:

Placebo volunteers will be administered one dose of placebo 1,5 hours before the exercise task for the acute testing and will be taking one dose per day of placebo for 4 days for the chronic testing.

Treatment:

Other: Placebo